- The emergence of next-generation sequencing (NGS) marked a major technological revolution in genomics and bioinformatics. It transformed DNA and RNA sequencing from relatively slow, expensive processes into high-throughput methods capable of analyzing millions of sequence fragments simultaneously. By dramatically increasing sequencing capacity and reducing the cost per base, NGS enabled researchers to investigate entire genomes, study gene expression, identify genetic variants, characterize microbial communities, and explore biological systems on an unprecedented scale. Its development helped establish modern genomics as a data-intensive scientific discipline in which computational analysis is essential for biological discovery.
- Before next-generation sequencing emerged, DNA sequencing was primarily performed using first-generation methods, particularly Sanger sequencing. Developed by Frederick Sanger and colleagues in the 1970s, Sanger sequencing became a foundational technique for determining DNA sequences and was widely used in molecular biology. It provided relatively accurate sequence information but generally processed limited numbers of DNA fragments per reaction compared with modern high-throughput technologies. Sequencing entire genomes therefore required extensive laboratory work, substantial time, and considerable financial resources. These limitations became especially apparent during large international projects such as the Human Genome Project, which demonstrated both the scientific value of genome sequencing and the need for more scalable technologies.
- The emergence of NGS resulted from advances in molecular biology, DNA chemistry, microfluidics, imaging, computer engineering, and computational data processing. Instead of determining the sequence of one DNA fragment at a time, NGS platforms were designed to sequence large numbers of DNA fragments in parallel. This approach, commonly described as massively parallel sequencing, increased throughput and made it possible to generate enormous volumes of sequence data in a single experiment. The resulting datasets required new computational methods for quality control, sequence alignment, genome assembly, variant detection, and biological interpretation.
- The transition toward next-generation sequencing accelerated during the mid-2000s. Early commercial platforms introduced sequencing-by-synthesis and other high-throughput approaches that substantially changed the scale of DNA sequencing. The 454 pyrosequencing platform, introduced commercially in the mid-2000s, was an early example of massively parallel sequencing. Other influential platforms, including Illumina sequencing systems and semiconductor-based sequencing technologies, expanded the range of sequencing applications. Although some early platforms were later discontinued or replaced, their development helped establish the technological principles underlying modern high-throughput sequencing.
- Different NGS platforms use different approaches to determine nucleotide sequences. Sequencing-by-synthesis technologies identify bases as DNA strands are copied, using signals generated during nucleotide incorporation. Illumina systems use fluorescently labelled reversible terminator nucleotides and imaging to identify bases across large numbers of sequencing clusters. Semiconductor sequencing detects changes associated with hydrogen ions released during nucleotide incorporation. Other technologies use ligation-based chemistry or alternative detection systems. These differences affect read length, throughput, error profiles, cost, and the types of biological questions that can be investigated.
- A typical NGS workflow begins with biological sample collection and nucleic acid extraction. DNA or RNA is isolated and assessed for quantity and quality. Depending on the application, the material may undergo fragmentation, target enrichment, complementary DNA synthesis, or other preparation steps. Sequencing libraries are then constructed by attaching platform-compatible adapters to the DNA fragments. The prepared libraries are loaded onto a sequencing instrument, where millions of fragments are read in parallel. The resulting raw data are processed through computational pipelines to generate usable sequence information.
- Bioinformatics is essential because NGS experiments produce far more data than can be interpreted manually. Raw sequencing reads undergo quality assessment to identify low-quality bases, adapter contamination, and other technical problems. Depending on the research objective, reads may be aligned to a reference genome or assembled into longer sequences without relying entirely on an existing reference. Subsequent analyses may include variant calling, gene expression quantification, transcript identification, taxonomic classification, or genome annotation. Researchers then interpret the results in the context of biological knowledge, statistical evidence, and the design of the experiment.
- Several major applications of NGS have transformed biological research. Whole-genome sequencing examines DNA across an organism’s genome, while whole-exome sequencing focuses on protein-coding regions. Targeted sequencing examines selected genes or genomic regions, often when a specific biological or clinical question is being investigated. RNA sequencing, or RNA-seq, measures RNA-derived sequences and helps researchers study gene expression, transcript diversity, alternative splicing, and changes in cellular activity. These methods enable researchers to investigate genetic variation and molecular processes at a scale that was difficult to achieve with earlier technologies.
- NGS has also become central to cancer genomics and medical genetics. By sequencing tumor and normal samples, researchers can identify somatic mutations, characterize genomic changes, and investigate the molecular mechanisms underlying cancer development. In inherited disease research, sequencing can help identify genetic variants associated with rare disorders and support diagnostic investigations. In infectious disease research, sequencing allows scientists to characterize pathogens, monitor genetic changes, investigate outbreaks, and track the evolution of viruses and bacteria. Clinical applications require careful validation, quality assurance, and interpretation because not every detected variant is medically significant.
- In microbiology and environmental science, metagenomic sequencing enables the analysis of genetic material obtained directly from environmental or biological samples. This makes it possible to investigate microbial communities without having to culture every organism separately. Researchers use metagenomics to study microorganisms in soil, oceans, wastewater, animal digestive systems, and the human microbiome. NGS also supports agricultural research by helping identify plant and animal genetic variants associated with productivity, disease resistance, adaptation, reproductive performance, and other important traits. In animal breeding, genomic information can contribute to genomic selection and more accurate estimation of breeding values when supported by appropriate reference populations and phenotypic data.
- The emergence of NGS also changed the scale and design of evolutionary and population-genetic studies. Researchers can examine genetic diversity across many individuals, identify population structure, investigate migration and ancestry, and detect genomic regions affected by natural or artificial selection. Comparative genomics uses sequencing data from different species or populations to study genome evolution and identify conserved or divergent regions. In conservation biology, sequencing can help assess genetic diversity, inbreeding, and relationships among endangered populations. These applications illustrate how high-throughput sequencing connects molecular data with broader questions about evolution, ecology, and biodiversity.
- Despite its advantages, NGS presents several technical and computational challenges. Sequencing reads can contain errors, and the accuracy and distribution of those errors vary between technologies. Short reads may be difficult to place uniquely in repetitive genomic regions, while complex structural variants can be challenging to reconstruct. Sample contamination, uneven sequencing coverage, biased library preparation, and differences in experimental design can affect results. Large datasets also require substantial storage, computing resources, and careful management. Reproducible analysis depends on suitable quality-control procedures, validated software, documented parameters, and transparent reporting.
- The development of long-read sequencing has expanded the capabilities of genomic analysis beyond those of many short-read platforms. Long-read technologies can produce substantially longer DNA sequences, helping researchers resolve repetitive regions, identify structural variants, phase genetic variants across chromosomes, and assemble more complete genomes. Some platforms detect nucleotide modifications directly or support their investigation through specialized analytical methods. Short-read and long-read technologies have complementary strengths, and combining them can improve genome assembly and variant characterization. The choice of platform depends on the research objective, required accuracy, read length, throughput, sample type, and available resources.
- More recent developments include single-cell sequencing, spatial transcriptomics, and multi-omics approaches. Single-cell sequencing allows researchers to study genetic or gene-expression differences between individual cells rather than averaging signals across a mixed population. Spatial transcriptomics links molecular measurements to locations within tissues, helping researchers investigate how cells interact within their physical environments. Multi-omics studies integrate genomic, transcriptomic, proteomic, epigenomic, and metabolomic information to provide a more comprehensive understanding of biological systems. These approaches increase the complexity of data analysis and create new demands for statistical modeling, data integration, and computational interpretation.
- Artificial intelligence and machine learning are increasingly used to support NGS analysis. These methods can assist with base calling, sequence classification, variant prioritization, gene annotation, and the prediction of functional effects. Machine-learning approaches can also help identify patterns in large genomic datasets that may be difficult to detect using conventional methods alone. However, model predictions depend on the quality and representativeness of training data, and their performance must be evaluated using suitable validation procedures. Computational predictions should be interpreted alongside experimental evidence and established biological knowledge.
- The growing use of NGS has also raised important ethical, legal, and social questions. Human genomic data can reveal sensitive information about individuals and their biological relatives, making privacy, informed consent, data security, and responsible data sharing essential considerations. Researchers must also address potential biases arising from the underrepresentation of particular populations in genomic databases. In clinical settings, sequencing results may include uncertain findings or incidental information that requires careful interpretation. Responsible genomic research therefore combines technical innovation with appropriate governance, transparency, and attention to equitable access.
- The emergence of next-generation sequencing fundamentally changed the relationship between sequencing technology and bioinformatics. High-throughput methods made large-scale biological data generation possible, while computational tools transformed those data into information about genes, genomes, variation, evolution, and biological function. The continuing development of short-read sequencing, long-read technologies, single-cell methods, multi-omics integration, and artificial intelligence is expanding the scope of genomic research. NGS remains one of the central technological foundations of modern bioinformatics, supporting advances in medicine, agriculture, biotechnology, microbiology, evolutionary biology, and environmental science.